Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/18725839/ below:

Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization

Affiliations

• ¹ Group Health Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA. miglioretti.d@ghc.org

• PMID: 18725839
• PMCID: PMC4227983
• DOI: 10.1097/MLR.0b013e31817946c8

Item in Clipboard

Diana L Miglioretti et al. Med Care. 2008 Sep.

• ¹ Group Health Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA. miglioretti.d@ghc.org

• PMID: 18725839
• PMCID: PMC4227983
• DOI: 10.1097/MLR.0b013e31817946c8

Item in Clipboard

Background: Screening for fecal occult blood can be effective in reducing colorectal cancer mortality only if positive tests are appropriately followed up with complete diagnostic evaluation (ie, colonoscopy or flexible sigmoidoscopy with double contrast barium enema) and treatment.

Objectives: To examine whether rates of complete diagnostic evaluation after a positive fecal occult blood test (FOBT) have improved over time after the implementation of tracking systems and physician guidelines within a large integrated health care organization.

Research design: From 1993 to 2005, 8513 positive FOBTs were identified on 8291 enrollees aged 50-79 of a large health care system. Automated records were used to identify repeat FOBTs, colonoscopy, flexible sigmoidoscopy, and double-contrast barium enema within 1 year after the positive FOBT. National rates of complete diagnostic evaluation were estimated from the 2005 National Health Interview Survey.

Results: In this integrated health care organization, the percentage of positive FOBTs followed by complete diagnostic evaluation within 1 year increased from 57-64% in 1993-1996 to 82-86% from 2000-2005. Use of repeat FOBT after a positive FOBT decreased from 28-31% in 1993-1996 to 6-11% in 2000-2005. Based on the National Health Interview Survey, only 52% of positive FOBTs in 2000-2005 were followed by complete diagnostic evaluation nationally.

Conclusions: Adherence to recommendations for complete diagnostic evaluation after a positive FOBT has greatly improved over time in an integrated group medical practice. Through the use of tracking systems and screening guidelines, it may be possible to reach levels of follow-up that are comparable to those observed in randomized trials.

PubMed Disclaimer

Percentage of positive FOBTs with…

Percentage of positive FOBTs with complete diagnostic evaluation by year of initial positive…

Percentage of positive FOBTs with complete diagnostic evaluation by year of initial positive fecal occult blood test and (a) number of positive slides per array, (b) gender, and (c) age.

• Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.

  Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, Quinn VP, Jensen CD, Chubak J, Tiro J, Doubeni CA, Ghai NR, Skinner CS, Wernli K, Halm EA. Singal AG, et al. Am J Gastroenterol. 2018 May;113(5):746-754. doi: 10.1038/s41395-018-0023-x. Epub 2018 Feb 27. Am J Gastroenterol. 2018. PMID: 29487413 Free PMC article.

• A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.

  Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, Cordes JE, Engelhard D. Church TR, et al. J Natl Cancer Inst. 2004 May 19;96(10):770-80. doi: 10.1093/jnci/djh134. J Natl Cancer Inst. 2004. PMID: 15150305 Clinical Trial.

• Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.

  Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS. Baig N, et al. Am J Gastroenterol. 2003 Sep;98(9):2078-81. doi: 10.1111/j.1572-0241.2003.07575.x. Am J Gastroenterol. 2003. PMID: 14499791

• Colorectal cancer screening.

  Inger DB. Inger DB. Prim Care. 1999 Mar;26(1):179-87. doi: 10.1016/s0095-4543(05)70108-1. Prim Care. 1999. PMID: 9922301 Review.

• Colorectal cancer screening.

  Borum ML. Borum ML. Prim Care. 2001 Sep;28(3):661-74, viii. doi: 10.1016/s0095-4543(05)70059-2. Prim Care. 2001. PMID: 11483450 Review.

• Longitudinal adherence with fecal occult blood test screening in community practice.

  Fenton JJ, Elmore JG, Buist DS, Reid RJ, Tancredi DJ, Baldwin LM. Fenton JJ, et al. Ann Fam Med. 2010 Sep-Oct;8(5):397-401. doi: 10.1370/afm.1133. Ann Fam Med. 2010. PMID: 20843880 Free PMC article.

• Barriers to completing colonoscopy after a positive fecal occult blood test.

  Azulay R, Valinsky L, Hershkowitz F, Elran E, Lederman N, Kariv R, Braunstein B, Heymann A. Azulay R, et al. Isr J Health Policy Res. 2021 Feb 11;10(1):11. doi: 10.1186/s13584-021-00444-2. Isr J Health Policy Res. 2021. PMID: 33573698 Free PMC article.

• Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality.

  San Miguel Y, Demb J, Martinez ME, Gupta S, May FP. San Miguel Y, et al. Gastroenterology. 2021 May;160(6):1997-2005.e3. doi: 10.1053/j.gastro.2021.01.219. Epub 2021 Feb 2. Gastroenterology. 2021. PMID: 33545140 Free PMC article.

• Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial.

  Green BB, Anderson ML, Wang CY, Vernon SW, Chubak J, Meenan RT, Fuller S. Green BB, et al. J Am Board Fam Med. 2014 Nov-Dec;27(6):789-95. doi: 10.3122/jabfm.2014.06.140125. J Am Board Fam Med. 2014. PMID: 25381076 Free PMC article. Clinical Trial.

• Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review.

  Selby K, Baumgartner C, Levin TR, Doubeni CA, Zauber AG, Schottinger J, Jensen CD, Lee JK, Corley DA. Selby K, et al. Ann Intern Med. 2017 Oct 17;167(8):565-575. doi: 10.7326/M17-1361. Epub 2017 Oct 10. Ann Intern Med. 2017. PMID: 29049756 Free PMC article. Review.

1. 1. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006;107:1711–42. - PubMed
2. 1. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut. 2002;50:840–4. - PMC - PubMed
3. 1. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007:CD001216. - PMC - PubMed
4. 1. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29–32. - PMC - PubMed
5. 1. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434–7. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3